AMBROXOL TECNIG*SYR FL 200ML

Ambroxol TecniGen 30 mg/10 ml syrup
Ambroxol
Generic medicine

What it is and what it is used for
Ambroxol TecniGen contains the active ingredient ambroxol, which belongs to the class of mucolytics. This medicine works by making mucus more fluid and thus easier to eliminate from the respiratory tract.

Ambroxol TecniGen is used for the treatment of secretions in diseases of the bronchi and lungs (acute and chronic bronchopulmonary conditions).

What you need to know before taking the medicine
Do not take Ambroxol TecniGen
- if you are allergic to ambroxol or any of the other ingredients of this medicine (listed in section 6);
- if you suffer from severe liver and/or kidney disease;
- if the patient is a child under 2 years of age (see "Children").

Warnings and precautions
Talk to your doctor or pharmacist before taking Ambroxol TecniGen.
Be especially careful with this medicine if you have stomach lesions (peptic ulcer).

Cases of severe skin reactions associated with ambroxol administration have been reported. If you develop a skin rash (including lesions of mucous membranes such as the mouth, throat, nose, eyes, genitals), stop taking Ambroxol TecniGen and contact your doctor immediately.

The medicine is not contraindicated if you suffer from celiac disease.

Children
Do not administer Ambroxol TecniGen syrup to children under 2 years of age, as mucolytics can induce airway obstruction (bronchial obstruction) in this age group, due to the physiological characteristics of the respiratory tract. In fact, the ability to drain bronchial mucus is limited in this age group, due to the physiological characteristics of the respiratory tract.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.

Rare (may affect up to 1 in 1,000 patients):
- fatigue;
- dry mouth;
- increased mucus production, runny nose;
- difficulty urinating;
- headache;
- heartburn and esophageal burn;
- indigestion;
- constipation;
- nausea and vomiting;
- contact dermatitis or other allergic reactions (especially skin rashes);
- hypersensitivity reactions;
- rash, urticaria;

Not known frequency (frequency cannot be estimated from the available data):
- airway obstruction (bronchial obstruction);
- anaphylactic reactions, including anaphylactic shock, angioedema (rapidly developing swelling of the skin, subcutaneous tissues, mucous membranes and submucosal tissues) and itching;
- severe cutaneous adverse reactions (including erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis and acute generalized exanthematous pustulosis).

Following the instructions in the package leaflet reduces the risk of side effects.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects, you can help provide more information on the safety of this medicine.